ArticleBMB reports2021
Low-dose metronomic doxorubicin inhibits mobilization and differentiation of endothelial progenitor cells through REDD1-mediated VEGFR-2 downregulation.
Minsik Park et al.PubMed ↗Full text ↗
No numbers read from the abstract.
10 papers cite it
this papercites it